These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2237832)

  • 41. cDNA sequence of rabbit lipoprotein-associated coagulation inhibitor.
    Wesselschmidt RL; Girard TJ; Broze GJ
    Nucleic Acids Res; 1990 Nov; 18(21):6440. PubMed ID: 2136251
    [No Abstract]   [Full Text] [Related]  

  • 42. Factor VII and extrinsic pathway inhibitor in acute coronary disease.
    Sandset PM; Sirnes PA; Abildgaard U
    Br J Haematol; 1989 Jul; 72(3):391-6. PubMed ID: 2788454
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A PstI RFLP of the LACI gene.
    van der Logt CP; Reitsma PH; Bertina RM
    Nucleic Acids Res; 1990 Oct; 18(19):5920. PubMed ID: 1977143
    [No Abstract]   [Full Text] [Related]  

  • 44. Refined regional assignment of the human tissue factor pathway inhibitor (TFPI) gene to chromosome band 2q32 by non-isotopic in situ hybridization.
    Van der Logt CP; Kluck PM; Wiegant J; Landegent JE; Reitsma PH
    Hum Genet; 1992 Jul; 89(5):577-8. PubMed ID: 1353057
    [No Abstract]   [Full Text] [Related]  

  • 45. Prevention of arterial reocclusion after thrombolysis with recombinant lipoprotein-associated coagulation inhibitor.
    Haskel EJ; Torr SR; Day KC; Palmier MO; Wun TC; Sobel BE; Abendschein DR
    Circulation; 1991 Aug; 84(2):821-7. PubMed ID: 1860224
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lipoprotein associated coagulation inhibitor, factor VII, antithrombin III, and monocyte tissue factor following surgery.
    Carson SD; Haire WD; Broze GJ; Novotny WF; Pirrucello SJ; Duggan MJ
    Thromb Haemost; 1991 Nov; 66(5):534-9. PubMed ID: 1803617
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A sensitive, accurate assay for extrinsic pathway inhibitor (EPI) activity in rabbit plasma: paradoxical effect of excess exogenous factor X.
    Warr TA; Rao LV; Rapaport SI
    Thromb Res; 1990 Aug; 59(4):773-82. PubMed ID: 2080494
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of heparin removal in vitro on the activity of tissue factor pathway inhibitor.
    Mukherjee M
    Br J Haematol; 2000 Nov; 111(2):714-5. PubMed ID: 11189101
    [No Abstract]   [Full Text] [Related]  

  • 49. Therapeutic fibrinolysis. What should follow?
    Stead NW
    Circulation; 1991 Aug; 84(2):948-50. PubMed ID: 1860243
    [No Abstract]   [Full Text] [Related]  

  • 50. Expression of tissue factor and tissue factor pathway inhibitor in porcine endothelium in response to natural antibody and complement.
    Nagayasu T; Saadi S; Holzknecht RA; Miyata Y; Plummer TB; Platt JL
    Transplant Proc; 2001; 33(1-2):788. PubMed ID: 11267072
    [No Abstract]   [Full Text] [Related]  

  • 51. Inhibition of human factor VIIa-tissue factor activity by placental anticoagulant protein.
    Kondo S; Noguchi M; Funakoshi T; Fujikawa K; Kisiel W
    Thromb Res; 1987 Nov; 48(4):449-59. PubMed ID: 2965430
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Correlation between anti-Xa and occurrence of thrombosis and haemorrhage in post-surgical patients treated with either Logiparin (LMWH) or unfractionated heparin. Post-surgery Logiparin Study Group.
    Bara L; Leizorovicz A; Picolet H; Samama M
    Thromb Res; 1992 Mar; 65(4-5):641-50. PubMed ID: 1319619
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Repeated release of the tissue factor pathway inhibitor.
    Ariëns RA; Faioni EM; Mannucci PM
    Thromb Haemost; 1994 Aug; 72(2):327-8. PubMed ID: 7831675
    [No Abstract]   [Full Text] [Related]  

  • 54. Activation of the tissue factor pathway occurs during continuous venovenous hemofiltration.
    Cardigan RA; McGloin H; Mackie IJ; Machin SJ; Singer M
    Kidney Int; 1999 Apr; 55(4):1568-74. PubMed ID: 10201024
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of the tissue factor-factor VII complex: involvement of factor Xa and lipoproteins.
    Hubbard AR; Jennings CA
    Thromb Res; 1987 May; 46(4):527-37. PubMed ID: 3617011
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of factor VIIa-tissue factor coagulation activity by a hybrid protein.
    Girard TJ; MacPhail LA; Likert KM; Novotny WF; Miletich JP; Broze GJ
    Science; 1990 Jun; 248(4961):1421-4. PubMed ID: 1972598
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Depletion of extrinsic pathway inhibitor (EPI) sensitizes rabbits to disseminated intravascular coagulation induced with tissue factor: evidence supporting a physiologic role for EPI as a natural anticoagulant.
    Sandset PM; Warn-Cramer BJ; Rao LV; Maki SL; Rapaport SI
    Proc Natl Acad Sci U S A; 1991 Feb; 88(3):708-12. PubMed ID: 1899482
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fucoidan, as heparin, induces tissue factor pathway inhibitor release from cultured human endothelial cells.
    Giraux JL; Tapon-Bretaudière J; Matou S; Fischer AM
    Thromb Haemost; 1998 Oct; 80(4):692-5. PubMed ID: 9798992
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor.
    Petersen LC; Sprecher CA; Foster DC; Blumberg H; Hamamoto T; Kisiel W
    Biochemistry; 1996 Jan; 35(1):266-72. PubMed ID: 8555184
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Coagulation factor VII and malignant progression of hepatocellular carcinoma.
    Chen KD; Huang KT; Tsai MC; Wu CH; Kuo IY; Chen LY; Hu TH; Chen CL; Lin CC
    Cell Death Dis; 2016 Feb; 7(2):e2110. PubMed ID: 26913602
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.